Global Nicotine Replacement Therapy (NRT) Products Market Professional Survey Report 2019
Nicotine replacement therapy (NRT) is a medically-approved way to take nicotine by means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting smoking by about 50% to 70%.Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of more than one type of NRT at a time may increase effectiveness.
The global Nicotine Replacement Therapy (NRT) Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nicotine Replacement Therapy (NRT) Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nicotine Replacement Therapy (NRT) Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nicotine Replacement Therapy (NRT) Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nicotine Replacement Therapy (NRT) Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Cipla
Novartis
GlaxoSmithKline
Takeda
McNeil
Revolymer
Imperial Tobacco
VMR products
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sprays
Inhalers
Chewing gums
Transdermal patches
Lozenges
Sublingual tablets
Segment by Application
Home
Hospital
The global Nicotine Replacement Therapy (NRT) Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nicotine Replacement Therapy (NRT) Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nicotine Replacement Therapy (NRT) Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nicotine Replacement Therapy (NRT) Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nicotine Replacement Therapy (NRT) Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Cipla
Novartis
GlaxoSmithKline
Takeda
McNeil
Revolymer
Imperial Tobacco
VMR products
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sprays
Inhalers
Chewing gums
Transdermal patches
Lozenges
Sublingual tablets
Segment by Application
Home
Hospital
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
